MedPath

skin sensitivity occlusive primary irritation patch test for 24hrs on healthy human volunteers

Not Applicable
Completed
Registration Number
CTRI/2018/02/012015
Lead Sponsor
ITC Life Sciences Technology Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
24
Inclusion Criteria

1.Subjects in age group 18 - 55 years (both the ages inclusive).

2.Healthy male & female subjects.

3.Subjects with Fitzpatrick skin type III to V.

4.Subjects willing to give a written informed consent.

5.Subjects willing to maintain the patch test in position for 24 hours.

6.Subject having not participated in a similar investigation in the past two weeks.

7.Subjects willing to come for regular follow up visits.

8.Subjects ready to follow instructions during the study period.

Exclusion Criteria

1.Infection, allergy on the tested area.

2.Skin allergy, antecedents or atopic subjects.

3.Athletes and subjects with history of excessive sweating.

4.Cutaneous disease which may influence the study result.

5.Subjects on oral corticosteroid with dose >10mg/day.

6.Subjects participating in any other cosmetic or therapeutic trial.

7.Any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the dermatological safety of the given investigational products on healthy human volunteers of varied skin types.Timepoint: 0hr,24hr and 7days post patch removal <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath